FewerJobs.
All jobs

Director, KAT6i (Prifetrastat) Launch Lead, US Breast Cancer

Pfizer - 2 Locations

Posted Nov 16, 2026

Benefits

Parental leave
12 weeks From the posting source
Non-birth-parent leave
12 weeks From the posting source
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Source-linked checked May 7, 2026
Salary
$177K-$294K From the posting source
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Role

Seniority
Staff Plus From the posting source

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Director, KAT6i (Prifetrastat) Launch Lead, US Breast Cancer 2 Locations ROLE SUMMARY Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you-across teams, roles, and the Pfizer enterprise. Join us to make history - for patients, for their families, for the future. Prifetrastat is Pfizer's first-in-class oral KAT6 inhibitor, in development with fulvestrant for adults with previously treated HR+/HER2- metastatic breast cancer (BC). Prifetrastat is the next wave of Pfizer's breast cancer portfolio and a chance to launch a new mechanism of action in a crowded post-CDK4/6 inhibitor landscape. This role leads US launch readiness for prifetrastat. You will own one integrated launch plan across the brand team, market development, access, and operations, and drive the cross-functional team to every milestone from pre-launch through approval and first patient. You will work in step with the Global Launch Team so the US plan reflects global strategy and US realities, and you will collaborate closely with Commercial, Medical, Legal, Regulatory, Market Access, Supply, Sales,

Read the full description at pfizer.wd1.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.

Apply at pfizer.wd1.myworkdayjobs.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs